AI and Organ-on-a-Chip Tech Face Reality Check in Animal Testing Phase-Out
Global regulators and advocacy groups are accelerating the transition away from animal testing, but a significant technological gap remains between current AI capabilities and biological complexity. While the FDA and EU now permit alternative data, experts warn that fully replacing animal models requires breakthroughs in multi-organ simulation.